Breast Cancer
Breast cancer HER-2/neu expression did not differ in African Americans and Caucasians
Published in Women's Health Weekly, July 27th, 2006
According to a study from the United States, "HER-2/neu overexpression in invasive mammary carcinoma is associated with more aggressive biologic behavior."
"Breast cancer in AA women has been associated with a shorter survival rate than that seen in C," explained M.A. Alabbadi and colleagues, Harper University Hospital. "This study evaluated the frequency of HER-2/neu overexpression in C compared to AA patients and the association of HER-2/neu expression with overall survival and other prognostic factors. A...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Allergy & Immunology
Avoiding antigens during lactation may not prevent occurrence of allergies in children - Breast Cancer
Racial differences in breast cancer risk may indicate need for updated risk estimates - Breast Cancer
Tamoxifen-treated breast cancer may influence progression of atypical endometrial lesions - Renal Cell Carcinoma
Risk of kidney cancer is associated with obesity in women - Uterine Cancer
One third of women treated with tamoxifen develop uterine cancer more than 12 months after therapy - Anesthesia
Laryngeal secretions may not be overly affected by topical anesthesia - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
